Abstract

MORADAS ESTRADA, M. Is necessary the remotion of old amalgam restorations?. Clinical and law evidence (II). Av Odontoestomatol [online]. 2018, vol.34, n.1, pp.35-39. ISSN 2340-3152.

After years of careful research and over 200 scientific reviews, the US Food and Drug Administration (FDA) reiterates that dental amalgam is a safe and effective material for the use of dental restorations. The American Dental Association (ADA) agrees with the US Food and Drug Administration (FDA) in its decision not to impose any restrictions on the use of dental amalgam, a commonly used filling material. “The FDA has left the decision about dental treatment right where it should be - between the dentist and the patient,” says Dr. John S. Findley, president of the ADA. “This decision underscores what the ADA has been advocating for a long time: A debate between dentists and patients about the wide variety of treatment options that will help patients be aware of their decisions regarding their dental health. “

The FDA resolution classifies encapsulated amalgam as a Class II medical device, placing it in the same class as the gold and composite fillings. The American Dental Association (ADA) has advocated class II designation for amalgam since the FDA first proposed it in 2002.

Keywords : Restorative materials; amalgam; mercury; cytotoxicity; passivation; corrosion; amalgam lobby; FDA amalgam; ADA AMALGAM.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )